Loss of miR-223 and JNK signaling contribute to elevated stathmin in malignant pleural mesothelioma

Molecular Cancer Research

Volumn 13, Issue 7, 2015, Pages 1106-1118

  Birnie, Kimberly A ^a   Yip, Yan Y ^b   Ng, Dominic C H ^b,c   Kirschner, Michaela B ^d   Reid, Glen ^d   Prêle, Cecilia M ^a   Musk, Arthur W ^e,f   Lee, Y C Gary ^a   Thompson, Philip J ^a   Mutsaers, Steven E ^a   Badrian, Bahareh ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 223; SMALL INTERFERING RNA; STATHMIN; STRESS ACTIVATED PROTEIN KINASE; TUBULIN; MICRORNA; MIRN223 MICRORNA, HUMAN; PARAFFIN; STMN1 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER PATIENT; CANCER TISSUE; CELL MOTILITY; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; FIBROBLAST; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MESOTHELIOMA CELL LINE; MESOTHELIUM CELL; MOUSE; NONHUMAN; PLEURA EFFUSION; PLEURA MESOTHELIOMA; PRIMARY CELL; PRIORITY JOURNAL; PROTEIN ACETYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; ANIMAL; AUSTRALIA; CELL MOTION; GENETICS; LUNG TUMOR; MESOTHELIOMA; METABOLISM; PATHOLOGY; PRIMARY CELL CULTURE; TUMOR CELL LINE;

ANIMALS; AUSTRALIA; CELL LINE, TUMOR; CELL MOVEMENT; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUNG NEOPLASMS; MAP KINASE SIGNALING SYSTEM; MESOTHELIOMA; MICE; MICRORNAS; PARAFFIN EMBEDDING; PRIMARY CELL CULTURE; STATHMIN;

EID: 84942304332     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-14-0442     Document Type: Article

References (48)

1. Spugnini EP, Bosari S, Citro G, Lorenzon I, Cognetti F, Baldi A. Human malignant mesothelioma: molecular mechanisms of pathogenesis and progression. Int J Biochem Cell Biol 2006; 38:2000-4.
2. Park E-K, Hannaford-Turner KM, Hyland RA, Johnson AR, Yates DH Asbestos-related occupational lung diseases in NSW, Australia and potential exposure of the general population. Ind Health 2008; 46:535-40.
3. He L, Hannon GJ MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5:522-31.
4. Drakaki A, Iliopoulos D. MicroRNA gene networks in oncogenesis. Curr Genomics 2009; 10:35-41.
5. Truini A, Coco S, Alama A, Genova C, Sini C, Dal Bello MG, et al Role of microRNAs in malignant mesothelioma. Cell Mol Life Sci 2014; 71: 2865-78.
6. Guled M, Lahti L, Lindholm PM, Salmenkivi K, Bagwan I, Nicholson AG, et al CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma - A miRNA microarray analysis. Genes Chromosomes Cancer 2009; 48:615-23.
7. Ivanov SV, Goparaju CMV, Lopez P, Zavadil J, Toren-Haritan G, Rosenwald S, et al Pro-tumorigenic effects of miR-31 loss in mesothelioma. J Biol Chem 2010; 285:22809-17.
8. Kubo T, Toyooka S, Tsukuda K, Sakaguchi M, Fukazawa T, Soh J, et al Epigenetic silencing of MicroRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma. Clin Cancer Res 2011; 17:4965-74.
9. ∗ is linked to the prognosis of malignant pleural mesothelioma. Cancer Res 2010; 70:1916-24.
10. Reid G, Pel ME, Kirschner MB, Cheng YY, Mugridge N, Weiss J, et al Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma. Ann Oncol 2013; 24:3128-35.
11. Fassina A, Cappellesso R, Guzzardo V, Dalla Via L, Piccolo S, Ventura L, et al Epithelial-mesenchymal transition in malignant mesothelioma. Mod Pathol 2012; 25:86-99.
12. Benjamin H, Lebanony D, Rosenwald S, Cohen L, Giborri H, Barabash N, et al A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma. J Mol Diagn 2010; 12: 771-9.
13. Santarelli L, Strafella E, Staffolani S, Amati M, Emanuelli M, Sartini D, et al Association of MiR-126 with soluble mesothelin-related peptides, a marker for malignant mesothelioma. PLoS ONE 2011; 6:e18232.
14. Weber DG, Johnen G, Bryk O, Jockel K-H, Bruning T. Identification of miRNA-103 in the cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma - a pilot study. PLoS ONE 2012; 7:e30221.
15. Kirschner MB, Cheng YY, Badrian B, Kao SC, Creaney J, Edelmann JJ, et al Increased circulating miR-625-3p: a potential biomarker for patients with malignant pleural mesothelioma. J Thorac Oncol 2012; 7:1184-91.
16. Li S, Li Z, Guo F, Qin X, Liu B, Lei Z, et al. miR-223 regulates migration and invasion by targeting Artemin in human esophageal carcinoma. J Biomed Sci 2011; 18:24.
17. Kang W, Tong JHM, Chan AWH, Lung RWM, Chau SL, Wong QWL, et al. Stathmin1 plays oncogenic role and is a target of MicroRNA-223 in gastric cancer. PLoS ONE 2012; 7:e33919.
18. Pulikkan JA, Dengler V, Peramangalam PS, PeerZada AA, Miller-Tidow C, Bohlander SK, et al. Cell-cycle regulator E2F1 and micro RNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. Blood 2010; 115:1768-78.
19. Stamatopoulos B, Meuleman N, Haibe-Kains B, Saussoy P, Van Den Neste E, Michaux L, et al. microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. Blood 2009; 113:5237-45.
20. Laios A, O'Toole S, Flavin R, Martin C, Kelly L, Ring M, et al Potetial role of miR-9 and miR-223 in recurrent ovarian cancer. Mol Cancer 2008; 7:35.
21. Wong QW, Lung RW, Law PT, Lai PB, Chan KY, To K-F, et al. MicroRNA-223 is commonly overexpressed in hepatocellular carcinoma and potrentiates expression of stathmin1. Gastroenterology 2008; 135:257-69.
22. Johnnidis JB, Harris MH, Wheeler RT, Stehling-Sun S, Lam MH, Kirak O, et al Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 2008; 451:1125-9.
23. Masciarelli S, Fontemaggi G, Di Agostino S, Donzelli S, Carcarino E, Strano S, et al Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells. Oncogene 2013; 33:1601-8.
24. Kim JY, Harvard C, You L, Xu Z, Kuchenbecker K, Baehner R, et al Stathmin is overexpressed in malignant mesothelioma. Anticancer Res 2007; 27: 39-44.
25. Bieche I, Maucuer A, Laurendeau I, Lachkar S, Spano AJ, Frankfurter A, et al Expression of stathmin family genes in human tissues: non-neural-restricted expression for SCLIP. Genomics 2003; 81:400-10.
26. Steinmetz MO Structure and thermodynamics of the tubulin-stathmin interaction. J Struct Biol 2007; 158:137-47.
27. Belletti B, Baldassarre G. Stathmin: a protein with many tasks. New biomarker and potential target in cancer. Expert Opin Ther Targets 2011; 15:1249-66.
28. Ahn J, Murphy M, Kratowicz S, Wang A, Levine AJ, George DL Down-regulation of the stathmin/Op18 and FKBP25 genes following p53 induction. Oncogene 1999; 18:5954-8.
29. Alli E, Yang JM, Hait WN Silencing of stathmin induces tumor-suppressor function in breast cancer cell lines harboring mutant p53. Oncogene 2007; 26:1003-12.
30. Carr JR, Park HJ, Wang Z, Kiefer MM, Raychaudhuri P. FoxM1 mediates resistance to herceptin and paclitaxel. Cancer Res 2010; 70:5054-63.
31. Chen Y, Lin MC, Yao H, Wang H, Zhang AQ, Yu J, et al Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin. Hepatology 2007; 46:200-8.
32. Singer S, Malz M, Herpel E, Warth A, Bissinger M, Keith M, et al Coordinated expression of stathmin family members by far upstream sequence element-binding protein-1 increases motility in non-small cell lung cancer. Cancer Res 2009; 69:2234-43.
33. Yeap YY, Ng IH, Badrian B, Nguyen TV, Yip YY, Dhillon AS, et al c-Jun N-terminal kinase/c-Jun inhibits fibroblast proliferation by negatively regulating the levels of stathmin/oncoprotein 18. Biochem J 2010; 430:345-54.
34. Lansley SM, Searles RG, Hoi A, Thomas C, Moneta H, Herrick SE, et al Mesothelial cell differentiation into osteoblast- and adipocyte-like cells. J Cell Mol Med 2011; 15:2095-105.
35. Kao SC, Yan TD, Lee K, Burn J, Henderson DW, Klebe S, et al Accuracy of diagnostic biopsy for the histological subtype of malignant pleural mesothelioma. J Thorac Oncol 2011; 6:602-5.
36. Fan M, Krutilina R, Sun J, Sethuraman A, Yang CH, Wu ZH, et al Comprehensive analysis of microRNA (miRNA) targets in breast cancer cells. J Biol Chem 2013; 288:27480-93.
37. Wu L, Li H, Jia CY, Cheng W, Yu M, Peng M, et al MicroRNA-223 regulates FOXO1 expression and cell proliferation. FEBS Lett 2012; 586:1038-43.
38. Trang P, Weidhaas J, Slack F. MicroRNAs as potential cancer therapies. Oncogene 2009; 27:52-7.
39. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, Bassi P, et al Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 2007; 25:387-92.
40. Li J, Guo Y, Liang X, Sun M, Wang G, De W, et al MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4. J Cancer Res Clin Oncol 2012; 138:763-74.
41. Jones KB, Salah Z, Del Mare S, Galasso M, Gaudio E, Nuovo GJ, et al miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res 2012; 72:1865-77.
42. lancu C, Mistry SJ, Arkin S, Wallenstein S, Atweh GF Effects of stathmin inhibition on the mitotic spindle. J Cell Sci 2000; 114:909-16.
43. Eguchi R, Fujimori Y, Takeda H, Tabata C, Ohta T, Kuribayashi K, et al Arsenic trioxide induces apoptosis through JNK and ERK in human mesothelioma cells. J Cell Physiol 2011; 226:762-8.
44. Jamal S, Cheriyan VT, Muthu M, Munie S, Levi E, Ashour AE, et al CARP-1 functional mimetics are a novel class of small molecule inhibitors of malignant pleural mesothelioma cells. PLoS One 2014; 9:e89146.
45. Hubner A, Mulholland DJ, Standen CL, Karasarides M, Cavanagh-Kyros J, Barrett T, et al JNK and PTEN cooperatively control the development of invasive adenocarcinoma of the prostate. Proc Natl Acad Sci U S A 2012; 109:12046-51.
46. Goparaju CM, Blasberg JD, Volinia S, Palatini J, Ivanov S, Donington JS, et al Onconase mediated NFK[beta] downregulation in malignant pleural mesothelioma. Oncogene 2011; 30:2767-77.
47. Hubbert C, Guardiola A, Shao R, Kawaguchi Y, Ito A, Nixon A, et al HDAC6 is a microtubule-associated deacetylase. Nature 2002; 417: 455-8.
48. Wu W, Tan XF, Tan HT, Lim TK, Chung MC Unbiased proteomic and transcript analyses reveal that stathmin-1 silencing inhibits colorectal cancer metastasis and sensitizes to 5-fluorouracil treatment. Mol Cancer Res 2014; 12:1717-28.